US wants China to import more GMO crops as part of trade deal

trade wars
Image: Sunday News

The United States is seeking better access for imports of genetically modified crops into China as part of a trade deal currently under discussion between the two sides, said two people familiar with the matter.

The subject, long a major irritant in agricultural trade between the countries, is a main issue for the U.S. Department of Agriculture, said a biotech industry source with knowledge of USDA discussions.

“I can say with full confidence that biotech is one of the key issues for USDA in this conversation with the Chinese,” the source said.

China does not permit planting of GMO food crops, but it does allow the import of GMO soybeans and corn for use in its huge animal feed industry.

However the approval process for new GMO strains is slow, unpredictable and not based on science, the biotech industry has said.

As the world’s top buyer of soybeans and a major buyer of other grains, China’s slow approval process stalls trade by forcing agrichemical firms to restrict sales of new products to American farmers until they get Beijing’s go-ahead.

Read full, original post: Exclusive: U.S. wants China to approve more biotech crops under trade deal – sources

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-Sep-2-2026-10_30_14-PM
Zero: That is the official American measles death toll for 2026. Here is what RFK Jr.’s CDC leaves out.
Screenshot-2026-09-10-at-12.20.19-PM
'Jet fuel didn't melt the steel': 9/11 conspiracy theories debunked
ChatGPT-Image-Sep-14-2026-11_36_25-AM
How the reckless AI race among Anthropic, OpenAI and China spawned today’s safety crisis
ChatGPT-Image-Sep-13-2026-10_24_17-AM
Bayer urges court to approve $7.25 billion Monsanto Roundup settlement that could limit its future liabilities
ChatGPT-Image-Aug-28-2026-03_33_46-PM
Viewpoint: Bad science—Five bogus Trump administration claims about vaccines and autism
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
screenshot at  am
‘Glyphosate is not carcinogenic’: Independent EU chemical oversight agency reaffirms—for the 3rd time in 9 years—that the herbicide is safe-as-used
Screenshot-2026-09-14-at-3.07.56-PM
Trump EPA rolls back power-plant climate rules—and moves to block future carbon limits
Screenshot-2026-09-14-at-10.52.30-AM
AI is being used in dangerous bioscience experiments
ChatGPT-Image-Sep-14-2026-02_57_24-PM
Viewpoint: 6 Atlantic Council expert opinions on the U.S., China and the AI safety crisis
Screenshot-2026-08-04-at-11.36.16-AM
Viewpoint: Emotion-driven stories of doctors allegedly ignoring patient concerns are driving vaccine hesitancy
ChatGPT-Image-Sep-13-2026-10_46_11-AM
“Hit the brakes”: Anthropic warns the race to superintelligence could spawn internet-seizing AI swarms—and empower authoritarians. Here’s how to stop it.
ChatGPT-Image-Aug-14-2026-11_16_47-AM
Fibermaxxing: Latest Instagram diet craze raises hope that a fiber-rich diet can improve health
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.